The activity of STAT proteins, particularly STAT3 is constitutively elevated in a wide range of solid tumors and hematological malignancies, where it functions as a critical mediator of oncogenic signaling through transcriptional activation of genes related with apoptosis, cell cycle regulation, and angiogenesis36, 37. Here, STAT3 is linked to hematologic disorder.